FDA Approves Drug for a Rare Disease Due Resulting from Phase I/II Clinical Trial
The drug, Ceriliponase alfa from BioMarin, helped in a condition that has led inexorably to disability and death: Batten Disease – specifically CLN2. Families of kids facing this prognosis are…